211 related articles for article (PubMed ID: 11395139)
1. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
[TBL] [Abstract][Full Text] [Related]
2. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
3. Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.
Hong SC; Waterbury G; Janeway CA
J Exp Med; 1996 Apr; 183(4):1437-46. PubMed ID: 8666902
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.
Matsuzawa A; Yasuda T; Sakamoto S; Nagase H; Nakano H; Yoshimoto T
Scand J Immunol; 2001 Jun; 53(6):553-62. PubMed ID: 11422903
[TBL] [Abstract][Full Text] [Related]
5. Structure-function studies of T-cell receptor-superantigen interactions.
Li H; Llera A; Mariuzza RA
Immunol Rev; 1998 Jun; 163():177-86. PubMed ID: 9700510
[TBL] [Abstract][Full Text] [Related]
6. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
Dyson PJ; Elliott JI
Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
8. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
Sheard MA; Sharrow SO; Takahama Y
Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259
[TBL] [Abstract][Full Text] [Related]
9. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
[TBL] [Abstract][Full Text] [Related]
10. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
11. TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas.
Gomez G; Clarkin KZ; Kraig E; Infante AJ; Richie ER
Int Immunol; 2000 Mar; 12(3):263-70. PubMed ID: 10700461
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
13. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
14. Rabies superantigen as a Vbeta T-dependent adjuvant.
Astoul E; Lafage M; Lafon M
J Exp Med; 1996 Apr; 183(4):1623-31. PubMed ID: 8666920
[TBL] [Abstract][Full Text] [Related]
15. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
Maillard I; Xenarios I; Diggelmann H; Orbea HA
Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
[TBL] [Abstract][Full Text] [Related]
16. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
17. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery.
Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T
Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484
[TBL] [Abstract][Full Text] [Related]
18. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
19. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
[TBL] [Abstract][Full Text] [Related]
20. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
